These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31122928)

  • 1. Exposing drug industry funding of UK patient organisations.
    Ozieranski P; Rickard E; Mulinari S
    BMJ; 2019 May; 365():l1806. PubMed ID: 31122928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In diabetes fight, raising cash and keeping trust.
    Santora M
    N Y Times Web; 2006 Nov; ():A1, B4. PubMed ID: 17167875
    [No Abstract]   [Full Text] [Related]  

  • 3. Advertising and disclosure of funding on patient organisation websites: a cross-sectional survey.
    Ball DE; Tisocki K; Herxheimer A
    BMC Public Health; 2006 Aug; 6():201. PubMed ID: 16887025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-operation between patient organisations and the drug industry in Finland.
    Hemminki E; Toiviainen HK; Vuorenkoski L
    Soc Sci Med; 2010 Apr; 70(8):1171-5. PubMed ID: 20163903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of the pharmaceutical industry in patient organisations].
    Vermeulen M; Bouma J
    Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2432-4. PubMed ID: 18064861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public sector funding in the UK.
    Owen DA
    Nat Biotechnol; 1998 May; 16 Suppl():64. PubMed ID: 9591278
    [No Abstract]   [Full Text] [Related]  

  • 7. Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs.
    Mulinari S; Vilhelmsson A; Rickard E; Ozieranski P
    PLoS One; 2020; 15(6):e0235021. PubMed ID: 32579571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 'patient-industry complex'? Investigating the financial dependency of UK patient organisations on drug company funding.
    Ozieranski P; Pitter JG; Rickard E; Mulinari S; Csanadi M
    Sociol Health Illn; 2022 Jan; 44(1):188-210. PubMed ID: 34874566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UK drug companies must disclose funding of patients' groups.
    Day M
    BMJ; 2006 Jan; 332(7533):69. PubMed ID: 16410564
    [No Abstract]   [Full Text] [Related]  

  • 10. CAM research funding in the UK: surveys of medical charities in 1999 and 2002.
    Wider B; Ernst E
    Complement Ther Med; 2003 Sep; 11(3):165-7. PubMed ID: 14659380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No Conflict, No Interest.
    Nipp RD; Moy B
    JAMA Oncol; 2016 Dec; 2(12):1631-1632. PubMed ID: 27560041
    [No Abstract]   [Full Text] [Related]  

  • 12. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.
    Perlis RH; Perlis CS; Wu Y; Hwang C; Joseph M; Nierenberg AA
    Am J Psychiatry; 2005 Oct; 162(10):1957-60. PubMed ID: 16199844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of the pharmaceutical industry on treatment guidelines].
    Kramers C; Wuis E; Schouwenberg B
    Ned Tijdschr Geneeskd; 2008 Jan; 152(2):114; author reply 114. PubMed ID: 18265803
    [No Abstract]   [Full Text] [Related]  

  • 14. UK nurses sponsored by pharmaceutical companies.
    Woodman R
    Lancet; 1996 Jun; 347(9014):1547. PubMed ID: 11656538
    [No Abstract]   [Full Text] [Related]  

  • 15. Study examines drug industry payments to physicians who establish cancer guidelines.
    Printz C
    Cancer; 2017 Mar; 123(5):723. PubMed ID: 28221686
    [No Abstract]   [Full Text] [Related]  

  • 16. Fisons investigates claims of excessive hospitality.
    Kingman S
    BMJ; 1993 Nov; 307(6915):1301-2. PubMed ID: 11643188
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relationships between patient associations and companies: ethical aspects].
    Roche G
    Presse Med; 2012 May; 41 Suppl 1():S45-7. PubMed ID: 22459992
    [No Abstract]   [Full Text] [Related]  

  • 18. Voluntary organisations. The luck of the draw?
    George M
    Nurs Stand; 1995 Feb 22-28; 9(22):20-1. PubMed ID: 7703125
    [No Abstract]   [Full Text] [Related]  

  • 19. AMA forges ahead. Unveiling of educational campaign paid by drug industry triggers new criticism.
    Romano M
    Mod Healthc; 2001 Sep; 31(37):22-3. PubMed ID: 11573355
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical ethics: funding the discourse.
    Roy N
    Issues Med Ethics; 2002; 10(2):20-1. PubMed ID: 16334924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.